SPONSOR
Mingzhi Zhang
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
NCT06559553 Phase 1, Phase 2
Recruiting
"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL
NKTCL
NCT06683885 Phase 1, Phase 2
Recruiting
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
Newly Diagnosed Diffuse Large B-cell Lymphoma